serum level of cc-chemokine ligand 18 is increased in patients with non-small-cell lung cancer and correlates with survival time in adenocarcinomas血清水平cc-chemokine 18增加配体在非小细胞肺癌患者和与腺癌生存时间.pdfVIP

serum level of cc-chemokine ligand 18 is increased in patients with non-small-cell lung cancer and correlates with survival time in adenocarcinomas血清水平cc-chemokine 18增加配体在非小细胞肺癌患者和与腺癌生存时间.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
serum level of cc-chemokine ligand 18 is increased in patients with non-small-cell lung cancer and correlates with survival time in adenocarcinomas血清水平cc-chemokine 18增加配体在非小细胞肺癌患者和与腺癌生存时间

Serum Level of CC-Chemokine Ligand 18 Is Increased in Patients with Non-Small-Cell Lung Cancer and Correlates with Survival Time in Adenocarcinomas ¨ 1 2 2 4 1 ¨ Till Plones , Alexander Krohn , Meike Burger , Hendrik Veelken , Bernward Passlick , Joachim Muller- 3 3 Quernheim , Gernot Zissel * 1 Department of Thoracic Surgery, University Medical Center Freiburg, Freiburg, Germany, 2 Department of Oncology and Haematology, University Medical Center Freiburg, Freiburg, Germany, 3 Department of Pneumology, University Medical Center Freiburg, Freiburg, Germany, 4 Department of Haematology, Leiden University Medical Center, Leiden, The Netherlands Abstract CC-chemokineligand18(CCL18)ismainlyexpressedbyalternativelyactivatedmacrophagesandDCsandplaysanimportantrole in lung fibrosis, arthritis and other diseases. Here CCL18 was measured in sera of 31healthy volunteers and 170 patients with lung cancerandcorrelatedthesedatawithhistology,tumorstageandclinicalparameters.MeanCCL18serumlevelofthepatientswith non-small-cell lung cancer was 150(857) ng/ml vs. 32(61) ng/ml in the healthy control group. Patient groups differ significantly accordingtheirhistology(adenocarcinoma143(528) ng/mlvssquamouscellcarcinoma187(857)ng/ml,p,0.02).Inaddition,we found a significant difference between patients with lower versus higher T-stage (p,0.003). Receiver operating characteristic (ROC)analysesrevealedacutoffpointof83 ng/ml(areaunderthecurve(AUC):0.968;p,0.0001)todiscriminatebetweenhealthy controls and non-small-cell lung cancer patients. ROC analyses to discriminate between patients, who died because of cancer relateddeathandthosewhodiedforotherreasonsdidnotleadtoavalidAUC. Tostratifythetumor patients,acrit

您可能关注的文档

文档评论(0)

xyz118 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档